Thomas Metzler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Thomas Metzler has a total of 159 co-authors. Here are the top co-authors by number of shared publications:
- Alec Steep
Center of Translational Data Science, University of Chicago, Chicago, Illinois
19 shared publications - Brian Theisen
Henry Ford Health System 8 Detroit, MI
19 shared publications - Daniel James Salas-Escabillas
Cancer Biology Program, University of Michigan-Ann Arbor
19 shared publications - Daniel W. Long
Department of Surgery, Henry Ford Pancreatic Cancer Center, Henry Ford Hospital, Detroit, Michigan
19 shared publications - Donald Rempinski
Department of Surgery, Henry Ford Health, Detroit, Michigan
19 shared publications - Erick T. Davis
Department of Surgery, Henry Ford Health, Detroit, Michigan
19 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
ROR2 regulates cell proliferation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
ROR2 regulates cell proliferation.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
Ror2 is expressed in pancreatic meta/neoplastic lesions with a gastric neck/SPEM cell-like identity.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
Ror2 is expressed in pancreatic meta/neoplastic lesions with a gastric neck/SPEM cell-like identity.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
The pit cell-like and the classical PDAC signature show a tight overlap.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
The pit cell-like and the classical PDAC signature show a tight overlap.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
Ablation of Ror2 promotes tissue transformation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
Ablation of Ror2 promotes tissue transformation.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
ROR2 promotes EMT and stemness.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
ROR2 promotes EMT and stemness.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 2 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
ROR2 is associated with gastric identity.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 2 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
ROR2 is associated with gastric identity.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
Using snATAC-seq to study early transformation of the pancreas.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma
Using snATAC-seq to study early transformation of the pancreas.
- Open Access
- 1 September 2025
- Published by Springer Nature in Nature Metabolism
- Vol. 7 (9) , 1-21
ATF6 activation alters colonic lipid metabolism causing tumour-associated microbial adaptation
Endoplasmic reticulum unfolded protein responses contribute to cancer development, with activating transcription factor 6 (ATF6) involved in microbiota-dependent tumorigenesis. Here we show the clinical relevance of ATF6 in individuals with early-onset and late colorectal cancer, and link ATF6 signalling to changes in lipid metabolism and intestinal microbiota. Transcriptional analysis in intestinal epithelial cells of ATF6 transgenic mice (nATF6IEC) identifies bacteria-specific changes in cellular metabolism enriched for fatty acid biosynthesis. Untargeted metabolomics and isotype labelling confirm ATF6-related enrichment of long-chain fatty acids in colonic tissue of humans, mice and organoids. FASN inhibition and microbiota transfer in germ-free nATF6IEC mice confirm the causal involvement of ATF6-induced lipid alterations in tumorigenesis. The selective expansion of tumour-relevant microbial taxa, including Desulfovibrio fairfieldensis, is mechanistically linked to long-chain fatty acid exposure using bioorthogonal non-canonical amino acid tagging, and growth analysis of Desulfovibrio isolates. We postulate chronic ATF6 signalling to select for tumour-promoting microbiota by altering lipid metabolism.
- 1 September 2025
- Published by Springer Nature in Nature Metabolism
- Vol. 7 (9) , 1-21
Open AccessATF6 activation alters colonic lipid metabolism causing tumour-associated microbial adaptation
Endoplasmic reticulum unfolded protein responses contribute to cancer development, with activating transcription factor 6 (ATF6) involved in microbiota-dependent tumorigenesis. Here we show the clinical relevance of ATF6 in individuals with early-onset and late colorectal cancer, and link ATF6 signalling to changes in lipid metabolism and intestinal microbiota. Transcriptional analysis in intestinal epithelial cells of ATF6 transgenic mice (nATF6IEC) identifies bacteria-specific changes in cellular metabolism enriched for fatty acid biosynthesis. Untargeted metabolomics and isotype labelling confirm ATF6-related enrichment of long-chain fatty acids in colonic tissue of humans, mice and organoids. FASN inhibition and microbiota transfer in germ-free nATF6IEC mice confirm the causal involvement of ATF6-induced lipid alterations in tumorigenesis. The selective expansion of tumour-relevant microbial taxa, including Desulfovibrio fairfieldensis, is mechanistically linked to long-chain fatty acid exposure using bioorthogonal non-canonical amino acid tagging, and growth analysis of Desulfovibrio isolates. We postulate chronic ATF6 signalling to select for tumour-promoting microbiota by altering lipid metabolism.